You can think outside the box. Or you can change it. Cerba Research has the global footprint, end-to-end capabilities, and scientific expertise to support your COVID-19 or other infectious disease clinical trial. Even in the face of change, Cerba means certainty. You can count on our speed, flexibility, and operational excellence to provide the integrated clinical and diagnostic laboratory solutions you need.

As an example, read our COVID-19 case study:

10-Day Study Start & Custom Test Kit Build at the Height of a Pandemic

As you know, with infectious disease, timing is critical. In 10 days, the Cerba Research team initiated complete central laboratory support for a Phase III clinical trial for a COVID-19 prophylactic, from rapid, accurate, in-house test kit development to cutting-edge laboratories that provide the full portfolio of harmonized laboratory testing services required in infectious disease research to unified global database build.